Cipla gains after acquiring 75% stake in Mabpharm
Source: IRIS | 18 Jul, 2014, 10.04AM
|
|
|
|
|
| Rating: NAN / 5 stars. |
 Comments | Post Comment |
|
 Cipla shares gained on Friday after the company has acquired additional 75% stake in Mabpharm through its wholly owned subsidiary Meditab Specialities.
 The company was earlier holding 25% stake in Mabpharm. Consequent to the acquisition of the aforesaid stake, Mabpharm has now become 100% subsidiary of the company.
Shares of the company are trading at Rs 441.15, up Rs 4, or 0.92% at the Bombay Stock Exchange (BSE) on Friday at 9:58 a.m.
The scrip has touched an intra-day high of Rs 443.60 and low of Rs 439.25. The total volume of shares traded at the BSE is 33,653.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
